In the latest quarter, 4 analysts provided ratings for Agios Pharmaceuticals (NASDAQ:AGIO), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts have recently evaluated Agios Pharmaceuticals and provided 12-month price targets. The average target is $54.25, accompanied by a high estimate of $56.00 and a low estimate of $51.00. A decline of 3.12% from the prior average price target is evident in the current averag…